(AP) --A half-price version of Eli Lilly's popular Humalog insulin is now available, following the company's promise in March to offer diabetics a more affordable option amid fierce criticism of ...

INDIANAPOLIS, May 27, 2015 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Humalog ® 200 units/mL KwikPen ® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a ...

NovoLog (insulin aspart) and Humalog (insulin lispro) are brand-name prescription medications. They’re approved by the Food and Drug Administration (FDA) to treat type 1 and type 2 diabetes in certain ...

Eli Lilly & Company LLY announced plans to launch lower-priced versions of two of its insulin product, Humalog – Humalog Mix75/25 KwikPen and Humalog Junior KwikPen. The list price of these low-priced ...

A half-price version of Eli Lilly's popular Humalog insulin is now on sale, following the company's promise in March to offer diabetics a more affordable option amid fierce criticism of soaring prices ...

For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does ...

Credit: Getty Images. Eli Lilly announced plans to launch an authorized generic version of Humalog (insulin lispro) 100 Units/mL at a 50% lower list price. Eli Lilly announced plans to launch an ...

Both Humalog and Novolog are rapid-acting types of insulin used to manage diabetes. But there are important distinctions between Humalog and Novolog, and the drugs are not directly interchangeable.

The FDA recently approved a 200 units/mL Humalog KwikPen, a pre-filled, rapid-acting insulin pen designed to improve glycemic control in people with type 1 and type 2 diabetes, Eli Lilly and Company ...

Drugmaker Eli Lilly will begin offering a cheaper version of its top-selling insulin after facing increasing pressure from lawmakers and the public about the rising costs of prescription drugs, ...

The drugmaker Eli Lilly will begin selling a cheaper version of its most popular insulin, Humalog, in an effort to head off criticism about the rising costs of prescription drugs, the company said ...